Ying Cheng

1.4k total citations
50 papers, 1.1k citations indexed

About

Ying Cheng is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ying Cheng has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Oncology. Recurrent topics in Ying Cheng's work include Effects of Radiation Exposure (10 papers), Nanoparticle-Based Drug Delivery (6 papers) and Immune Response and Inflammation (6 papers). Ying Cheng is often cited by papers focused on Effects of Radiation Exposure (10 papers), Nanoparticle-Based Drug Delivery (6 papers) and Immune Response and Inflammation (6 papers). Ying Cheng collaborates with scholars based in China and United States. Ying Cheng's co-authors include Siyuan Zhou, Miao Liu, Bang‐Le Zhang, Qibing Mei, Daozhou Liu, Han Cui, Qifeng Ji, Fu Gao, Jianming Cai and Bailong Li and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Ying Cheng

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Cheng China 19 514 184 160 153 153 50 1.1k
Daozhou Liu China 19 526 1.0× 278 1.5× 84 0.5× 276 1.8× 91 0.6× 27 1.1k
Yu Tian China 20 674 1.3× 144 0.8× 204 1.3× 109 0.7× 241 1.6× 60 1.4k
Haiyang Yu China 23 867 1.7× 166 0.9× 195 1.2× 110 0.7× 327 2.1× 92 1.9k
Hassan Dariushnejad Iran 17 453 0.9× 72 0.4× 135 0.8× 123 0.8× 103 0.7× 47 908
Xuguang Zhang China 20 639 1.2× 72 0.4× 96 0.6× 40 0.3× 208 1.4× 78 1.4k
Litai Jin China 23 1.0k 1.9× 74 0.4× 109 0.7× 66 0.4× 154 1.0× 81 1.8k
Xiaoyan Yu China 17 477 0.9× 204 1.1× 239 1.5× 135 0.9× 101 0.7× 34 1.0k
Amir R. Afshari Iran 25 753 1.5× 158 0.9× 111 0.7× 166 1.1× 249 1.6× 76 1.7k

Countries citing papers authored by Ying Cheng

Since Specialization
Citations

This map shows the geographic impact of Ying Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Cheng more than expected).

Fields of papers citing papers by Ying Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Cheng. The network helps show where Ying Cheng may publish in the future.

Co-authorship network of co-authors of Ying Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Cheng. A scholar is included among the top collaborators of Ying Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Cheng. Ying Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ying, Zhifu Yang, Qifeng Ji, et al.. (2024). Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction. Journal of Nanobiotechnology. 22(1). 93–93. 12 indexed citations
2.
Fang, Yi, Yulun Wu, Lihui Wei, et al.. (2024). miR-326 overexpression inhibits colorectal cancer cell growth and proteasome activity by targeting PNO1: unveiling a novel therapeutic intervention strategy. Scientific Reports. 14(1). 24284–24284. 1 indexed citations
3.
Liu, Liya, Yuying Han, Lihui Wei, et al.. (2024). Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway. Chinese Journal of Integrative Medicine. 30(6). 515–524. 3 indexed citations
4.
Wang, Di, Ying Cheng, Meizhu Wu, et al.. (2023). Quercetin attenuates angiotensin II‐induced proliferation of vascular smooth muscle cells and p53 pathway activation in vitro and in vivo. BioFactors. 49(4). 956–970. 6 indexed citations
5.
Wen, Ying, Xiuli Zhang, Lihui Wei, et al.. (2023). Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology analysis. Frontiers in Pharmacology. 14. 1082281–1082281. 12 indexed citations
6.
Zhang, Xiuli, Ying Wen, Lihui Wei, et al.. (2022). Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway. Frontiers in Pharmacology. 12. 770863–770863. 17 indexed citations
7.
Ali, Farman, Aling Shen, Waqar Islam, et al.. (2021). Role of MicroRNAs and their corresponding ACE2/Apelin signaling pathways in hypertension. Microbial Pathogenesis. 162. 105361–105361. 5 indexed citations
8.
Cheng, Ying, Miao Liu, Qifeng Ji, et al.. (2021). Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme. Journal of Controlled Release. 336. 54–70. 56 indexed citations
9.
Cheng, Ying, Jianfeng Chu, Meizhu Wu, et al.. (2021). Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway. Biomedicine & Pharmacotherapy. 143. 112124–112124. 26 indexed citations
10.
Cheng, Ying, Jianfeng Chu, Zhiqing Shen, et al.. (2021). Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo. Biomedicine & Pharmacotherapy. 137. 111318–111318. 25 indexed citations
11.
Shen, Zhiqing, Youqin Chen, Li Li, et al.. (2020). Transcription Factor EBF1 Over-Expression Suppresses Tumor Growth in vivo and in vitro via Modulation of the PNO1/p53 Pathway in Colorectal Cancer. Frontiers in Oncology. 10. 1035–1035. 15 indexed citations
12.
Shen, Zhiqing, Xiangyan Wu, Jianfeng Chu, et al.. (2020). Huoxin pill attenuates myocardial infarction-induced apoptosis and fibrosis via suppression of p53 and TGF-β1/Smad2/3 pathways. Biomedicine & Pharmacotherapy. 130. 110618–110618. 18 indexed citations
13.
Zhang, Pei, Hainan Zhao, Ying Cheng, et al.. (2018). Radioprotective effects of roxadustat (FG‐4592) in haematopoietic system. Journal of Cellular and Molecular Medicine. 23(1). 349–356. 14 indexed citations
14.
Cheng, Ying, Suhe Dong, Pei Zhang, et al.. (2017). Zymosan-a Protects the Hematopoietic System from Radiation-Induced Damage by Targeting TLR2 Signaling Pathway. Cellular Physiology and Biochemistry. 43(2). 457–464. 11 indexed citations
15.
Cheng, Ying, Xuguang Hu, Cong Liu, et al.. (2017). Gelsolin Inhibits the Inflammatory Process Induced by LPS. Cellular Physiology and Biochemistry. 41(1). 205–212. 40 indexed citations
16.
17.
Huang, Yijuan, Hainan Zhao, Ding Sun, et al.. (2016). Radioprotective Effect of Grape Seed Proanthocyanidins In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity. 2016(1). 5706751–5706751. 15 indexed citations
18.
Gao, Fu, Chaoxiong Zhang, Weimin Sun, et al.. (2015). A critical role of toll-like receptor 2 (TLR2) and its’ in vivo ligands in radio-resistance. Scientific Reports. 5(1). 13004–13004. 23 indexed citations
19.
Cheng, Ying, Miao Liu, Huijing Hu, Daozhou Liu, & Siyuan Zhou. (2015). Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation. AAPS PharmSciTech. 17(2). 409–417. 26 indexed citations
20.
Gao, Fu, Cong Liu, Jiaming Guo, et al.. (2015). Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer. Scientific Reports. 5(1). 9613–9613. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daozhou Liu Breakdown of academic impact, for papers by Yu Tian Breakdown of academic impact, for papers by Haiyang Yu Breakdown of academic impact, for papers by Hassan Dariushnejad Breakdown of academic impact, for papers by Xuguang Zhang Breakdown of academic impact, for papers by Litai Jin Breakdown of academic impact, for papers by Xiaoyan Yu Breakdown of academic impact, for papers by Amir R. Afshari
Rankless by CCL
2026